Registry for women with preeclampsia and related conditions
Official title: The Preeclampsia Registry
Run by Preeclampsia Foundation · NCT06377878 · Data updated 2026-11-12
This study is collecting health information from women with preeclampsia and related conditions to help researchers learn more about the causes and find better treatments for this serious pregnancy issue.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 13 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Preeclampsia Foundation Academic / other |
| Locations | 1 site (Melbourne, Florida) |
| Status | Recruiting |
| Started | September 1, 2013 |
| Main results expected | May 2040 |
| Study ends | May 2040 |
| Registry record updated | April 22, 2024 |
| Trial ID | NCT06377878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women diagnosed with preeclampsia or related hypertensive disorders, their family members, and women who have never experienced these conditions.
✕Probably not a fit
Patients who are unable to provide consent, prisoners, or those who cannot speak English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Preeclampsia Registry aims to collect and store medical information from women diagnosed with preeclampsia and related hypertensive disorders, as well as their family members and healthy controls. This observational study utilizes a web-based survey and medical record review to gather data that will help researchers understand the causes and mechanisms of preeclampsia. The information collected will support immediate research projects and may lead to the development of new treatments and diagnostic approaches for this serious pregnancy complication. Participants may also be contacted for future studies or to provide biospecimens.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of preeclampsia, potentially reducing risks for mothers and babies.
How similar studies have gone: Other studies have shown success in utilizing registries for understanding pregnancy-related complications, making this approach both relevant and promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women who were medically diagnosed with preeclampsia or a related hypertensive disorder of pregnancy (HDP) such as eclampsia or HELLP syndrome. * Female or Male relatives of affected women * Women who have never had preeclampsia or hypertensive disorders of pregnancy, but who would like to serve as "controls" in research studies of preeclampsia. * An authorized representative may complete the questionnaire and provide consent for a woman who had preeclampsia, but has died or is disabled as a result. Exclusion Criteria: * Those unable to provide consent * Prisoners * Individuals unable to speak English
Where it's running
-
Preeclampsia Foundation
Melbourne, Florida, United States Recruiting
Study contacts
- Principal investigator: Eleni Z Tsigas, BA — Preeclampsia Foundation
- Study coordinator: VeeAnn Argyle
- Email: Registry@preeclampsia.org
- Phone: 321-421-6957
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Kidney and heart prevention program after preeclampsia
This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Preeclampsia Biomarker Test in African Women
This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.
-
Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders
This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.
-
Progesterone to Prevent Preeclampsia in Early Pregnancy
This trial tests whether nightly vaginal progesterone started before 12 weeks can lower the chance of preeclampsia in low-risk pregnant people.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.